Theophylline in Dextrose (B. Braun Medical Inc.)


Welcome to the PulseAid listing for the Theophylline in Dextrose drug offered from B. Braun Medical Inc.. This Methylxanthine [EPC],Xanthines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: B. Braun Medical Inc.
NON-PROPRIETARY NAME: Theophylline Anhydrous and Dextrose
SUBSTANCE NAME: THEOPHYLLINE ANHYDROUS; DEXTROSE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Methylxanthine [EPC],Xanthines [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1992-08-14
END MARKETING DATE: 0000-00-00


Theophylline in Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTheophylline in Dextrose from B. Braun Medical Inc.
LABELER NAME: B. Braun Medical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 80; 5(mg/100mL; g/100mL)
START MARKETING DATE: 1992-08-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0264-9554_5df8f4d8-1afb-48e9-9175-768cf77c3064
PRODUCT NDC: 0264-9554
APPLICATION NUMBER: NDA019826

Other THEOPHYLLINE ANHYDROUS; DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Theophylline in Dextrose